ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how our rules link it today.

6 links0 made here, not in the record7 judgments1 judge (our rules as one)0 record changes seen
Our rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04577963A Study of Fruquintinib inCombination WithTislelizumab in AdvancedSolid TumorsHutchmedPhase 1/Phase 2 · terminatedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSTriple Negative Breast Neop…The registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionEndometrial NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termColorectal NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termBreast NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Wider: a narrower term is filedWider: a narrower term is filedDRUGSHMPL-013Entry “Fruquintinib”, read by our nam…›As of now · Our role rule · TestedTestedTislelizumabIntervention entry›As of now · Our role rule · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Triple Negative Breast Neoplasms

From the registry record2 judgments on this link
Kind of condition link, from the registry to what was judged
RegistryTriple Negative Breast Neoplasms, as filedthe registry files the study under it
→judged
Main condition (R9)

All judgments on this study

WhenLinkJudgeDecisionState
Nov 14Triple Negative Breast NeoplasmsOur condition-kind ruleFinest filed termCurrent
Nov 14Endometrial NeoplasmsOur condition-kind ruleFinest filed termCurrent
Nov 14Colorectal NeoplasmsOur condition-kind ruleFinest filed termCurrent
Nov 14Breast NeoplasmsOur condition-kind ruleWider: a narrower term is filedCurrent
As of nowTriple Negative Breast NeoplasmsOur main-condition rule (R9)Main conditionCurrent
As of nowHMPL-013Our role ruleTestedCurrent
As of nowTislelizumabOur role ruleTestedCurrent